ZA200103485B - N-Arylsulfonyl amino acid omega amides. - Google Patents

N-Arylsulfonyl amino acid omega amides. Download PDF

Info

Publication number
ZA200103485B
ZA200103485B ZA200103485A ZA200103485A ZA200103485B ZA 200103485 B ZA200103485 B ZA 200103485B ZA 200103485 A ZA200103485 A ZA 200103485A ZA 200103485 A ZA200103485 A ZA 200103485A ZA 200103485 B ZA200103485 B ZA 200103485B
Authority
ZA
South Africa
Prior art keywords
alkyl
formula
hydrogen atom
compound
sulfonylamino
Prior art date
Application number
ZA200103485A
Other languages
English (en)
Inventor
Wilfried Schwab
Werner Thorwart
Manfred Schudok
Burkhard Haase
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of ZA200103485B publication Critical patent/ZA200103485B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200103485A 1998-11-06 2001-04-30 N-Arylsulfonyl amino acid omega amides. ZA200103485B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19851184A DE19851184A1 (de) 1998-11-06 1998-11-06 N-Arylsulfonyl-aminosäure-omega-amide

Publications (1)

Publication Number Publication Date
ZA200103485B true ZA200103485B (en) 2001-12-04

Family

ID=7886902

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200103485A ZA200103485B (en) 1998-11-06 2001-04-30 N-Arylsulfonyl amino acid omega amides.

Country Status (23)

Country Link
US (2) US6201130B1 (pt)
EP (1) EP1124797B1 (pt)
JP (1) JP4348014B2 (pt)
KR (1) KR100655632B1 (pt)
CN (1) CN1206213C (pt)
AR (1) AR021086A1 (pt)
AT (1) ATE260889T1 (pt)
AU (1) AU757602B2 (pt)
BR (1) BR9915729A (pt)
CA (1) CA2350031C (pt)
CZ (1) CZ302291B6 (pt)
DE (2) DE19851184A1 (pt)
DK (1) DK1124797T3 (pt)
ES (1) ES2213405T3 (pt)
HK (1) HK1041686B (pt)
HU (1) HUP0104122A3 (pt)
ID (1) ID28810A (pt)
PL (1) PL198827B1 (pt)
PT (1) PT1124797E (pt)
RU (1) RU2228330C2 (pt)
TR (1) TR200101245T2 (pt)
WO (1) WO2000027808A1 (pt)
ZA (1) ZA200103485B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
US7071223B1 (en) * 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
EP1615886A1 (en) * 2003-04-15 2006-01-18 Warner-Lambert Company LLC [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
EP1626962B1 (en) * 2003-05-12 2007-02-28 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
MXPA06014022A (es) * 2004-06-29 2007-02-08 Pfizer Prod Inc Prcedimientos para preparar inhibidores de p2x7.
CA2572119A1 (en) * 2004-06-29 2006-01-12 Warner-Lambert Company Llc Combination therapies utilizing benzamide inhibitors of the p2x7 receptor
MXPA06015273A (es) * 2004-06-29 2007-03-15 Pfizer Prod Inc Procedimiento para preparar derivados de 5-[4-(2-hidroxi -etil)-3, 5-dioxo-4, 5-dihidro-3h-[1, 2, 4]-triazin -2-il]-benzamida con actividad inhibidora de p2x7 mediante reaccion del derivado no sustituido en posicion 4 de la triazina con un oxirano en
US7576222B2 (en) 2004-12-28 2009-08-18 Wyeth Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
PE20070505A1 (es) 2005-07-11 2007-05-15 Wyeth Corp Inhibidores de glutamato de metaloproteinasas de matriz y agrecanasas
KR20080058436A (ko) 2005-10-13 2008-06-25 와이어쓰 글루탐산 유도체의 제조 방법
ES2533065T3 (es) 2010-07-09 2015-04-07 Pfizer Limited Bencenosulfonamidas útiles como inhibidores de los canales de sodio
CA2900116C (en) * 2013-02-06 2021-08-10 Merck Patent Gmbh Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1063026A1 (ru) * 1982-05-19 1990-12-07 Институт биохимии АН ЛитССР N @ -Бензолсульфонильные производные трес-DL-фенилсерина, обладающие противовоспалительной активностью
JP2764262B2 (ja) 1987-08-28 1998-06-11 持田製薬株式会社 ヒダントイン誘導体及びそれを有効成分とする医薬組成物
TW201303B (pt) 1990-07-05 1993-03-01 Hoffmann La Roche
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
CN1151157A (zh) 1994-06-22 1997-06-04 英国生物技术药物有限公司 金属蛋白酶抑制剂
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
EP0837901A1 (en) * 1995-06-28 1998-04-29 E.I. Du Pont De Nemours And Company Fluoropolymer nanocomposites
KR980009238A (ko) 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
EP0901466B1 (en) * 1996-05-17 2001-10-31 Warner-Lambert Company Biphenylsulfonamide matrix metalloproteinase inhibitors
DE19719621A1 (de) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren

Also Published As

Publication number Publication date
HK1041686B (zh) 2005-09-23
DK1124797T3 (da) 2004-07-05
CN1332724A (zh) 2002-01-23
KR20010080385A (ko) 2001-08-22
CA2350031C (en) 2010-01-26
CA2350031A1 (en) 2000-05-18
PT1124797E (pt) 2004-07-30
HK1041686A1 (en) 2002-07-19
ATE260889T1 (de) 2004-03-15
DE19851184A1 (de) 2000-05-11
EP1124797A1 (de) 2001-08-22
RU2228330C2 (ru) 2004-05-10
JP4348014B2 (ja) 2009-10-21
CZ302291B6 (cs) 2011-02-09
ID28810A (id) 2001-07-05
AR021086A1 (es) 2002-06-12
CN1206213C (zh) 2005-06-15
US6201130B1 (en) 2001-03-13
HUP0104122A3 (en) 2002-04-29
HUP0104122A2 (hu) 2002-03-28
CZ20011506A3 (cs) 2001-08-15
TR200101245T2 (tr) 2001-10-22
DE59908769D1 (de) 2004-04-08
US6335333B1 (en) 2002-01-01
BR9915729A (pt) 2001-10-23
KR100655632B1 (ko) 2006-12-12
JP2002529447A (ja) 2002-09-10
WO2000027808A1 (de) 2000-05-18
EP1124797B1 (de) 2004-03-03
AU1153000A (en) 2000-05-29
PL347574A1 (en) 2002-04-08
ES2213405T3 (es) 2004-08-16
AU757602B2 (en) 2003-02-27
PL198827B1 (pl) 2008-07-31

Similar Documents

Publication Publication Date Title
AU732723B2 (en) Sulfonylaminocarboxylic acids
JP4177484B2 (ja) 置換されたジアミノカルボン酸
EP0873312B1 (en) Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors
NZ232195A (en) Phenyl-, pyridyl- and thienyl-substituted carboxamide and sulphonamide derivatives and pharmaceutical compositions
ZA200103485B (en) N-Arylsulfonyl amino acid omega amides.
CA2237382A1 (en) Substituted 6- and 7-amino-tetrahydroisoquinolinecarboxylic acids
US6586467B2 (en) Preparation of phosphatase inhibitors
US6326516B1 (en) Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
RU2224762C2 (ru) Производные фосфиновых и фосфоновых кислот, способ их получения и фармацевтическая композиция на их основе
KR20010101733A (ko) 아세틸렌계 아릴 설폰아미드 및 포스핀산 아미드하이드록삼산 티에이씨이 억제제
RU2196768C2 (ru) Замещенные диаминокарбоновые кислоты
MXPA01004394A (en) N-arylsulfonyl amino acid omega amides
MXPA01000400A (en) Phosphinous and phosphonic acid derivatives used as medicaments
KR20010101731A (ko) 헤테로아릴 아세틸렌계 설폰아미드 및 포스핀산 아미드하이드록삼산 티에이씨이 억제제
MXPA01007470A (es) Inhibidores de tace de aril-sulfonamida acetilenica y acido fosfinico-acido amido-hidroxamico
MXPA98003661A (en) Acids sulfonilaminocarboxili